Breast care involves decisions that cross specialties, from assessing inherited risk to supporting patients after treatment. The 35th NCoBC conference brings these perspectives together for clinicians, imaging professionals, navigators, and breast center leaders. Its listed sessions examine genetics, imaging, surgery, systemic and radiation therapy, metastatic disease, and survivorship. Practical topics include managing treatment toxicity, discussing menopause and psychosocial needs, and coordinating care across services. Quality measures and program development add an organizational perspective to the clinical material. The retained topic list below shows the supplied session titles so you can assess how the content fits your work.
Conference details: Organized by the National Consortium of Breast Centers at the Huntington Convention Center of Cleveland, Ohio. The main interdisciplinary conference ran March 28–29, 2026, followed by post-conference programs on March 30.
Package scope: The topic list below preserves the titles supplied with this listing. It does not establish coverage of every conference or post-conference activity. Official registration, NCBC certification eligibility, account or app access, and provider credit-claiming services are not included.
Learning Objectives
Upon completion of this program, participants should be better able to:
- Expand expertise in the evaluation and management of benign breast disease and high-risk breast care.
- Integrate the latest advancements in cancer genetics, genomics, and risk-reducing medications into clinical practice.
- Understand radiation risks, imaging technologies, and the role of technologists in breast imaging.
- Navigate controversies in shared decision-making and optimize care delivery for advanced metastatic cancer.
- Manage treatment toxicities and address psychosocial needs in survivorship care.
- Track and improve facility quality performance metrics using the National Quality Measures for Breast Centers (NQMBC) program.
The broader official conference objectives also address breast cancer risk assessment, imaging strategies, artificial intelligence, high-risk lesions, genetic predisposition, survivorship, clinical trial diversity, navigation, quality improvement, and program development.
Topics
-
Advancing Breast Surgery Innovations You Can Use Now
-
AI Entering the Workforce
-
Beyond the Curtain: Unveiling Imaging Pearls in High-Risk Breast Care
-
Biomarkers and Precision Medicine in Practice
-
Breakfast Symposia: A Nurses Guide for Management of Dermatologic Adverse Events DAEs Associated with Cancer Treatments
-
Breakfast Symposia: Cleveland Clinic Experience with SCOUT Radar Localization and SCOUT MD The Intermountain Healthcare Experience
-
Breakfast Symposia: Follow the Yellow Brick Road Emerging Evidence New Directions in Breast Cancer Risk Assessment
-
Breast Cancer Staging Major Changes Coming in 2027
-
Cancer Prevention and Risk Reduction in Women with Hereditary Cancer Syndromes
-
Caught in the Cyclone: Managing Breast Cancer Risk Before it Takes Flight
-
Factor or Fiction: Understanding Radiation Risk Associated with Imaging Exams
-
Going to the Chapel: The Marriage of Radiation and Systemic Therapy For Better or Worse
-
Good Witch Bad Witch: Lifestyle and Environmental Factors that Shape Breast Cancer Risk
-
High Risk and Genetics Case Discussion Session 1 & 2
-
Impact Award Winner Announced & Presentation
-
Inspiration Award Recognition
-
Keynote: From Diagnosis to Destiny Transforming Trauma into Purpose in Breast Cancer Care
-
MedOnc Milestones: Practical Advances That Will Shape the Future
-
Metastatic Breast Cancer: Refining Survivorship
-
Minimizing Toxicity with Early Intervention Focus on Gonadotoxicity Neuropathy and Alopecia
-
Models for Care: Managing Short Long-Term Immune Toxicity
-
Modernizing High Risk Care Insights from VHCs CARE Integration
-
Navigating the Care Matrix: A Real-Life Experience
-
Navigating the Yellow Brick Road to NAPBC Standards
-
Opening Comments 2, 3, and General
-
Optimizing Care Delivery in Advanced Metastatic Cancer
-
Over The Positive and Negative Rainbow: The Complexities of Germline Testing
-
Panel Controversies in Clinic: Shared Decision Making in Action
-
Psychosocial Precision in the Outcomes of Cancer Care
-
RadOnc Advances: Translating Progress into Practice
-
Remote Care: Community Concern vs Celebration
-
The Courage to Change: Policy Updates for Hereditary Cancer Patients
-
The Future of Breast Cancer Imaging: Updates on PETFES CT Scans
-
The Great and Powerful Guidelines Updates on NCCNASCO – Genomic vs Germline
-
The Pink Elephant in the Room: Addressing Menopause and the Breast Cancer Survivor Care Vacuum
-
The Wizardry Behind Understanding Genetic Variants
-
The Wizards Models for Cancer Risk: Understanding Tyrer Cuzick Gail and PREMM5
-
What’s New in Surgical Techniques: We are Not in Kansas Anymore
-
When Comorbidities Compete: What You Need to Know in Geriatric Oncology




